Discover open access scientific publications

Search, annotate, share and cite publications

Publications by C. M. Annunziata

Vandetanib, Designed to Inhibit VEGFR2 and EGFR Signaling, Had No Clinical Activity as Monotherapy for Recurrent Ovarian Cancer and No Detectable Modulation of VEGFR2

Clinical Cancer Research

Cancer Research

Oncology

2010

English

Molecular Pathways: The Balance Between Cancer and the Immune System Challenges the Therapeutic Specificity of Targeting Nuclear Factor- B Signaling for Cancer Treatment

Clinical Cancer Research

Cancer Research

Oncology

2016

English

Related publications

Computational Model of VEGFR2 Pathway to ERK Activation and Modulation Through Receptor Trafficking

Cellular Signalling

Cell Biology

2013

English

VEGF-A/VEGFR2 Signaling Network in Endothelial Cells Relevant to Angiogenesis

Journal of Cell Communication and Signaling

English

AIP1 Functions as an Endogenous Inhibitor of VEGFR2-mediated Signaling and Inflammatory Angiogenesis in Mice

Journal of Clinical Investigation

Medicine

2008

English

SKLB-287, a Novel Oral Multikinase Inhibitor of EGFR and VEGFR2, Exhibits Potent Antitumor Activity in LoVo Colorectal Tumor Model

Neoplasma

Cancer Research

2014

English

In Vivo Monitoring of Fetoplacental Vegfr2 Gene Activity in a Murine Pregnancy Model Using a Vegfr2-Luc Reporter Gene and Bioluminescent Imaging

Reproductive Biology and Endocrinology

Gynecology

Endocrinology

Reproductive Medicine

Developmental Biology

Obstetrics

2011

English

VEGFR2-PLC 1 Axis Is Essential for Endothelial Specification of VEGFR2+ Vascular Progenitor Cells

Journal of Cell Science

Cell Biology

2009

English

VEGFR2 Trafficking, Signaling and Proteolysis Is Regulated by the Ubiquitin Isopeptidase USP8

English

Discovery of Novel Potent VEGFR2 Inhibitors Exerting Significant Antiproliferative Activity Against Cancer Cell Lines

English

Combination Therapy With VEGFR2 and EGFR siRNA Enhances the Antitumor Effect of Cisplatin in Non-Small Cell Lung Cancer Xenografts

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by C. M. Annunziata

Vandetanib, Designed to Inhibit VEGFR2 and EGFR Signaling, Had No Clinical Activity as Monotherapy for Recurrent Ovarian Cancer and No Detectable Modulation of VEGFR2

Molecular Pathways: The Balance Between Cancer and the Immune System Challenges the Therapeutic Specificity of Targeting Nuclear Factor- B Signaling for Cancer Treatment

Related publications

Computational Model of VEGFR2 Pathway to ERK Activation and Modulation Through Receptor Trafficking

VEGF-A/VEGFR2 Signaling Network in Endothelial Cells Relevant to Angiogenesis

AIP1 Functions as an Endogenous Inhibitor of VEGFR2-mediated Signaling and Inflammatory Angiogenesis in Mice

SKLB-287, a Novel Oral Multikinase Inhibitor of EGFR and VEGFR2, Exhibits Potent Antitumor Activity in LoVo Colorectal Tumor Model

In Vivo Monitoring of Fetoplacental Vegfr2 Gene Activity in a Murine Pregnancy Model Using a Vegfr2-Luc Reporter Gene and Bioluminescent Imaging

VEGFR2-PLC 1 Axis Is Essential for Endothelial Specification of VEGFR2+ Vascular Progenitor Cells

VEGFR2 Trafficking, Signaling and Proteolysis Is Regulated by the Ubiquitin Isopeptidase USP8

Discovery of Novel Potent VEGFR2 Inhibitors Exerting Significant Antiproliferative Activity Against Cancer Cell Lines

Combination Therapy With VEGFR2 and EGFR siRNA Enhances the Antitumor Effect of Cisplatin in Non-Small Cell Lung Cancer Xenografts